Isa Krd News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The combination of Isa-KRd significantly increased the rates of minimal residual disease negativity at cutoffs post-consolidation vs KRd in patients with newly diagnosed multiple myeloma.

Azienda ospedaliero universitaria cittUniversity of torinoHealth sciencesSecond revision of international staging systemDepartment of molecular biotechnologyInternational staging systemInternational myeloma working groupMolecular biotechnologySecond revisionRevised international staging systemIsa krdIskia trialMrd negativity ratesNewly diagnosed multiple myeloma